Search results

15 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC researchers create safe and effective synthetic blood thinner
The effects of this new low-molecular-weight synthetic heparin can be quickly reversed unlike the effects of low-molecular-weight heparin currently in use.
Located in News / 2014 / February
‘Conversations with Innovators:’ UNC hematologist on promising drug trials for treating painful crises in sickle cell patients
Kenneth Ataga, MD, director of the UNC Comprehensive Sickle Cell Program, was featured in a video by the American Society of Hematology in which he discussed the favorable results of a yearlong clinical trial studying crizanlizumab as a therapy to prevent and treat painful crisis events in patients with sickle cell disease.
Located in News
Sydney and Sheridan, a Dynamic Duo
Patient ambassadors, Sydney and Sheridan, are sisters who have never known life without sickle cell anemia, a rare genetic disease affecting the shape of their red blood cells.
Located in UNC Children's News / / CARE 2014 / Issue 9
Sydney & Sheridan
Sisters Sydney and Sheridan are shining stars. Older sister, Sydney, age 13, fills her free time with cheerleading, and 9-year-old Sheridan with dancing and singing. Looking at them, you’d never know they both struggle with sickle cell anemia. For them, life means daily medications, periodic surgeries and frequent medical visits at UNC, yet the sisters live each day to its fullest potential. This is Sydney and Sheridan’s story.
Located in UNC Children's News / News / Calendar Kids
Chase R.
Four-year-old Chase spent half a year at N.C. Children's Hospital, nearly 300 miles from home in Franklin, NC, battling acute lymphoblastic leukemia (ALL) and rare complications related to his treatment.
Located in UNC Children's News / / Calendar Kids / 2011 Archive